Clinical Trial Update: Bioseal Dural Sealing Study BIOS-14-001 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Bioseal Dural Sealing (BIOS-14-001) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Tumors
• Malignant Tumors
• Vascular Malformation

Drugs mentioned

• Bioseal Dural Sealing

Snippet

Sponsor: Guangzhou Bioseal Biotechnology Co., Ltd. | Conditions: Benign Tumors, Malignant Tumors | Phase 3 | Status: COMPLETED